Regeneron Pharmaceuticals, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

9,711

Value ($000)

7,496

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,496	0.0%	9,711	12/31/2025
2025 Q2	8/13/2025	11,553	0.0%	22,005	6/30/2025
2025 Q1	5/13/2025	30,329	0.0%	47,820	3/31/2025
2024 Q4	2/12/2025	58,072	0.1%	81,524	12/31/2024
2024 Q3	11/13/2024	99,869	0.1%	95,001	9/30/2024
2024 Q2	8/12/2024	77,668	0.1%	73,897	6/30/2024
2024 Q1	5/14/2024	78,314	0.1%	81,366	3/31/2024
2023 Q4	2/14/2024	37,190	0.0%	42,344	12/31/2023
2023 Q3	11/14/2023	27,522	0.0%	33,443	9/30/2023
2023 Q2	8/11/2023	34,175	0.0%	47,562	6/30/2023
2023 Q1	5/11/2023	115,411	0.2%	140,459	3/31/2023
2022 Q4	2/10/2023	116,827	0.2%	161,925	12/31/2022
2022 Q3	11/14/2022	101,443	0.2%	147,262	9/30/2022
2022 Q2	8/11/2022	35,372	0.1%	59,188	6/30/2022
2022 Q1	5/16/2022	34,618	0.0%	49,998	3/31/2022
2021 Q4	2/14/2022	18,210	0.0%	28,836	12/31/2021
2021 Q3	11/12/2021	27,315	0.0%	45,134	9/30/2021
2021 Q2	8/13/2021	14,695	0.0%	26,311	6/30/2021
2021 Q1	5/28/2021	11,615	0.0%	24,549	3/31/2021
2020 Q4	2/16/2021	12,659	0.0%	26,203	12/31/2020
2020 Q3	11/13/2020	16,469	0.0%	29,159	9/30/2020
2020 Q2	8/13/2020	9,160	0.0%	14,686	6/30/2020
2020 Q1	5/15/2020	1,698	0.0%	3,366	3/31/2020
2019 Q4	2/11/2020	628	0.0%	1,673	12/31/2019
2014 Q1	5/15/2014	1,040	0.0%	3,464	3/31/2014
2013 Q4	2/14/2014	953	0.0%	3,464	12/31/2013